Mitsui Chemicals, Inc. · TSE:4183
Mitsui Chemicals — Investor Presentation (May 2026)
34 slides from Mitsui Chemicals's investor presentation, May 27, 2026
Slide 1: FY26-1 CEO Presentation
FY26-1 Chemistry for Sustainable World CEO PRESENTATION 市村 聡 ICHIMURA Satoshi Mitsui Chemicals Inc. President & CEO May 27, 2026 Copyright © 2026 Mitsui Chemicals, Inc.
Slide 2: Contents
May 27, 2026 Contents Business Performance FY25 results and full-year outlook for FY26 VISION 2030 Pursuing business portfolio transformation Working to become a truly global specialty company under our new management structure Copyright © 2026 Mitsui Chemicals, Inc.
Slide 3: FY25 Results and Full-Year Outlook for FY26
3 FY25 Results and Full-Year Outlook for FY26 May 27, 2026 Operating income before special items increased in our specialty chemicals domains, but remained negative in Basic & Green Materials due to factors such as low operating rates and inventory valuation losses in FY25. We expect steady profit g
Slide 4: Financial Targets: Numerical Trends
4 Financial Targets: Numerical Trends May 27, 2026 While our specialty chemicals domains are driving Group-wide earnings, capital efficiency remains an issue due to a continued deficit in B&GM and impairment loss, and we are accelerating business portfolio transformation to improve capital efficienc
Slide 5: Cash Flow Trends: Improving Earning Power
5 Cash Flow Trends: Improving Earning Power May 27, 2026 Improving our earning power through profit growth and an asset-light approach, in turn generating cash to make proactive growth investments and bolster shareholder returns Improved operating 250 （JPY bn） 2,500 cash flow level 200 （Boosting ear
Slide 6: Shareholder Returns
6 Shareholder Returns May 27, 2026 Planning to provide stable and continuous shareholder returns even in uncertain circumstances 80 150 ■ Dividends (interim) Dividend increase +5yen/share ● Repurchase of own shares and cancellation ■ Dividends (year-end) 70 ■ Memorial 110 Dividend increase of treasu
Slide 7: Rolling Out a Social Issue Perspective in All of Our Businesses
Pursuing Business Portfolio Transformation 7 Rolling Out a Social Issue Perspective in All of Our Businesses May 27, 2026 Sales revenue from certified products is Gross profit is also increasing steadily increasing, steadily as is its ratio to total sales revenue 40% 4040% % 40% Blue Value products
Slide 8: Contents
May 27, 2026 Contents Business Performance FY25 results and full-year outlook for FY26 VISION 2030 Pursuing business portfolio transformation Working to become a truly global specialty company under our new management structure Copyright © 2026 Mitsui Chemicals, Inc.
Slide 9: Approach to Pursuing Business Portfolio Transformation
9 Approach to Pursuing Business Portfolio Transformation May 27, 2026 VISION 2030 Current phase onward ～2030 Active investment Organic growth New businesses + M&A Specialty chemicals L&HC & returns Ophthalmic lens materials Around existing areas Ophthalmic lens & coating materials of focus domains m
Slide 10: Response to the Middle East Conflict and Strategic Direction of B&GM
10 Response to the Middle East Conflict and Strategic Direction of B&GM May 27, 2026 Main short-term measures B&GM ① Endeavor to maintain stable supply by procuring naphtha from regions outside the Middle East and increasing operating rates from July onward Group ② Raise prices to reflect the soarin
Slide 11: Strengthening the Competitiveness of Chemical Complexes and Achieving Shift to Green Chemicals
11 Strengthening the Competitiveness of Chemical Complexes and Achieving Shift to Green Chemicals May 27, 2026 Partnering with other companies to strengthen the competitiveness of chemical complexes at our sites in both east and west Japan and achieving shift to green chemicals, in turn supporting J
Slide 12: Creating Markets for Bio-Based/Chemically Recycled Products
12 Creating Markets for Bio-Based/Chemically Recycled Products May 27, 2026 Chemical recycling demonstration for polyurethane mattresses launched with Paramount Bed and Rever （2023.9.4） Biomass Evolue adopted for Japan Airlines (JAL) cargo handling materials（2025.10.2） Start of a collaborative proje
Slide 13: Our Approach Under the New Leadership Team
13 Our Approach Under the New Leadership Team May 27, 2026 ◆ The global chemical industry is at an unprecedented turning point ◆ With world-class products and technologies, our Group has the potential to generate growth ◆ As industry realignment gains momentum worldwide, we have an opportunity to re
Slide 14: A Truly Global Specialty Company – Current Status
14 A Truly Global Specialty Company – Our Perspective: Current Status May 27, 2026 ROS 40% Global specialty Bubble size: 35% Operating income before special items（absolute value） 30% Individual business Specialty chemicals 25% domains 20% 15% ICT L&HC 10% 5% Mobility 0% -5% -10% 20% 30% 40% 50% 60%
Slide 15: Main Products for Global Rollout in the Specialty Chemicals Domains
15 Main Products for Global Rollout in the Specialty Chemicals Domains May 27, 2026 L&HC Mobility ICT Global acquisition of peripheral technologies Global market leader Ophthalmic lens No. 1 No. 1 APEL in the world materials in the world (smartphone lenses) Pellicle No. 1 Investment and partnerships
Slide 16: Region-Based Expansion & Local Production for Local Consumption
16 A Truly Global Specialty Company – Our Perspective: Region-Based Expansion & Local Production for Local Consumption May 27, 2026 ◆ Conducting business across multiple overseas sites with established local-production-for-local-consumption operations ◆ Contributing to customer value creation as a s
Slide 17: Region-Based & Field-Based Expansion
17 A Truly Global Specialty Company – Our Perspective: Region-Based & Field-Based Expansion May 27, 2026 ➡ The coating materials business under vision care in Life & Healthcare Solutions has achieved strong top-line growth through organic growth, as well as M&As targeting peripheral technologies and
Slide 18: Solutions Delivery Capabilities
18 A Truly Global Specialty Company – Our Perspective: Solutions Delivery Capabilities May 27, 2026 ◆ Providing solutions tailored to the characteristics and needs of each region, even for businesses centered on exports from Japan ➡ For ICROS Tape, we are establishing and strengthening technical sup
Slide 19: Region-Based Expansion through Partnerships
19 A Truly Global Specialty Company – Our Perspective: Region-Based Expansion through Partnerships May 27, 2026 ➡ In agrochemical products, by leveraging our highly competitive active ingredients, we develop and sell formulations that meet local needs through capital and business partnerships with l
Slide 20: Global R&D Framework
20 A Truly Global Specialty Company – Our Perspective: Global R&D Framework May 27, 2026 ◆ To strengthen solutions delivery capabilities and accelerate the creation of new businesses and products: • Cross-business technical support capabilities and development capabilities closely aligned with marke
Slide 21: A Global Specialty Company – Numerical Targets
21 A Global Specialty Company – Our Perspective: Numerical Targets May 27, 2026 Aiming for L&HC and ICT to reach global specialty status within 2–3 years, and for our specialty chemicals domains as a whole to achieve this by FY2030 ROS 25% Specialty chemicals Global specialty domains (FY28) 20% Dire
Slide 22: Key Priorities for Becoming a Truly Global Specialty Company
22 Key Priorities for Becoming a Truly Global Specialty Company May 27, 2026 In the specialty chemicals domains, make substantial resource investments in L&HC, which offers stable growth, and ICT, which offers high growth potential Target higher-than-market growth Differentiation × Field-based expan
Slide 23: Global Rollout of Specialty Chemicals Domains
23 Global Rollout of Specialty Chemicals Domains May 27, 2026 Looking to supplement our organic growth in existing markets by actively investing resources in new markets and growth markets based on each region’s social environment and market needs FY09 (Post-GFC) FY25 FY30 Asia, etc. 15% Asia, etc.
Slide 24: Approach to Speeding Up Global Rollouts to Key Regions
24 Approach to Speeding Up Global Rollouts to Key Regions May 27, 2026 Key region Status of main businesses Approaches to consider ◆ Low sales ratio for L&HC for what is the largest healthcare market; development ◆ Leveraging solid income as a here is ongoing foundation to actively invest resources,
Slide 25: Looking Back on Our M&A Efforts
25 Looking Back on Our M&A Efforts May 27, 2026 M&A in area ④ (new technologies in new markets) ③ is a challenging endeavor, and requires time to bear fruit e.g. Foreign ④ High difficulty level New agrochemical e.g. Kulzer, ARRK Progress toward Kulzer restructuring Bold restructuring enabling steady
Slide 26: My First Initiative as CEO: Growth and Evolution
26 My First Initiative as CEO: Growth and Evolution May 27, 2026 The growth of our customers The growth and evolution of The evolution of each individual the Mitsui Chemicals Group Considered by issue-specific task-force teams Ideal state Issues for consideration across organizational boundaries ✓ G
Slide 27: Approach to Improving Our Ability to Offer Solutions
27 Measures for Our 100-Day Plan: Approach to Improving Our Ability to Offer Solutions May 27, 2026 Selecting technologies to focus on based on what value we can provide to markets and customers, then leveraging these technologies across businesses to bolster our ability to offer solutions Core Core
Slide 28: Our Approach to Evolving Production Technology
28 Measures for Our 100-Day Plan: Our Approach to Evolving Production Technology May 27, 2026 Sorting our efforts into two categories (“incident-driven measures” and “efforts to realize the plant’s ideal state”) and making steady progress on each 1) Incident-driven Leveraging analyses of past plant
Slide 29: Aiming to Increase Corporate Value
29 Aiming to Increase Corporate Value May 27, 2026 Planning to promptly achieve ROE above cost of equity & expand the spread to enhance our corporate value via business portfolio transformation, going asset-light, bolstering shareholder returns, etc. ✓ Investing further resources in fields and regio
Slide 30: Summary of Targets-1
30 Reference Summary of Targets-1 May 27, 2026 FY22 FY23 FY24 FY25 FY26 FY28 FY30 Results Results Results Results Outlook Target Target Operating income before special items 114 96 101 100 105 200 250 (B yen) Net income attributable to 150 or 83 50 32 34 45 110 owners of the more parent (B yen) 10%
Slide 31: Summary of Targets-2
31 Reference Summary of Targets-2 May 27, 2026 Contributing to a sustainable society Material topics KPIs FY25 Results FY26 Outlook FY30 Target • Climate change • Circular economy Blue Value products sales revenue ratio • 30% • 29% • 40% • Health and livelihood Rose Value products sales revenue rati
Slide 32: Summary of Targets-3
32 Reference Summary of Targets-3 May 27, 2026 Abilities essential to business continuity Material topics KPIs FY25 Results FY26 Outlook FY30 Target • Corporate Improvement of employee engagement culture Engagement score • 38% • 42％ ・50％ Key talent management Successor coverage rate for critical pos
Slide 33: A global solutions company that leads change and contributes to a sustainable future
A global solutions company that leads change and contributes to a sustainable future
Slide 34: Chemistry for Sustainable World
Chemistry for Sustainable World Challenge Diversity One Team Statements made in this document with respect to Mitsui Chemicals' current plans, estimates, strategies, and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Mitsui C